# AOGU

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aogu

- Industry: Healthcare
- Headquarters: Japan
- Website: https://corp.aogu-care.com
- Total disclosed funding: $0.3M
- Latest round: Seed (Mar 24, 2026)
- Investors on record: 1

## About

Based in Japan, AOGU, Inc. d.b.a AOGU provides innovative healthcare solutions focusing on enhancing patient outcomes through telehealth services and medical devices.AOGU, Inc. specializes in healthcare technology, founded in Japan in 2025. The company was established with a focus on delivering advanced telehealth services. On March 24, 2026, AOGU raised JPY 55 million in SEED funding from Coreline Ventures, marking a significant milestone as it announced its first deal. This funding supports the company's evolution in telehealth solutions.Aogu Care specializes in developing innovative healthcare solutions aimed at improving patient outcomes and enhancing the quality of care. The company's core product offerings include a range of telehealth services and medical devices designed for remote monitoring and diagnosis. These products address critical use cases such as chronic disease management, post-operative care, and preventive health assessments by enabling healthcare providers to track patient health metrics in real time. Aogu Care serves a diverse clientele that includes hospitals, outpatient clinics, and private practices primarily across North America, Europe, and parts of Asia. By providing scalable and user-friendly solutions, the company caters to the distinct needs of healthcare professionals and patients alike, significantly impacting their ability to deliver timely and effective care.The revenue model of Aogu Care is built around a subscription-based framework for its telehealth services, alongside direct sales of its medical devices. Customers typically enter into annual contracts for ongoing access to premium features of the telehealth platform, which allows for a seamless integration of remote consultations and health monitoring. Furthermore, the company engages in direct-to-consumer sales for its flagship medical devices, offering specialized pricing plans that cater to both individual users and institutional buyers. Transactions are structured to promote long-term partnerships with healthcare providers, enabling bulk purchasing options for clinics and hospitals while also allowing consumers the flexibility of one-time purchases. This dual approach to revenue generation reinforces Aogu Care's commitment to accessibility and innovation in healthcare delivery.In March 2026, AOGU raised JPY 55 million in SEED funding from Coreline Ventures. The company will use this funding to further refine its AI dialogue capabilities, enhance device design for more intuitive daily use, and strengthen its teams across AI, hardware, and dementia care expertise. AOGU plans to expand its market reach, focusing on increasing its presence in Europe and Asia by the end of 2027, as well as launching new telehealth products designed for chronic care management.

## Funding rounds

- Seed, Mar 24, 2026, $0.3M — Coreline Ventures

## Investors

- Coreline Ventures (https://capitalatlas.ai/funds/coreline-ventures) — Seed